Bio Essence Corp (BIOE) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US09090C1053

Price
0.44 USD
Market cap
23.68 m USD
P/E (2025)
22.00
P/S (2025)
12.48
Dividend yield
0.00 %
Net margin
47.23 %
Return on equity (ROE)
-43.23 %
Return on assets (ROA)
212.13 %

Bio Essence Corp financials

Fiscal year20242025
Revenue323,940.00 USD1.90 m USD
Gross profit217,077.00 USD1.43 m USD
Operating income-459,438.00 USD900,011.00 USD
EBIT-1.31 m USD899,183.00 USD
Net income-1.31 m USD896,197.00 USD
Diluted EPS – continuing operations-0.03 USD0.02 USD

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Bio Essence Corp

Bio Essence Corporation engages in manufacturing and distributing health supplement products. It also offers original equipment manufacturing, and private label services for dietary supplements, vitamins, and herbal nutrition products. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.